Nomogram for Prediction of Prostate Cancer with Serum Prostate Specific Antigen Less than 10 ng/mL

Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy is still necessary to confirm prostate cancer (PCA). However, it is reported that PSA is associated with a high false-positive rate and prostate biopsy also has various procedure-related complications. Therefor...

Full description

Saved in:
Bibliographic Details
Published inJournal of Korean medical science Vol. 29; no. 3; pp. 338 - 342
Main Authors Ahn, Jae Hyun, Lee, Jeong Zoo, Chung, Moon Kee, Ha, Hong Koo
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Academy of Medical Sciences 01.03.2014
대한의학회
Subjects
Online AccessGet full text
ISSN1011-8934
1598-6357
1598-6357
DOI10.3346/jkms.2014.29.3.338

Cover

Abstract Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy is still necessary to confirm prostate cancer (PCA). However, it is reported that PSA is associated with a high false-positive rate and prostate biopsy also has various procedure-related complications. Therefore, the authors have devised a nomogram, which can be used to estimate the risk of PCA, using available clinical data for men with a serum PSA less than 10 ng/mL. Prostate biopsies were obtained from 2,139 patients from January 1998 to March 2011. Of them, 1,171 patients with a serum PSA less than 10 ng/mL were only included in this study. Patient age, PSA, free PSA, prostate volume, PSA density and percent free PSA ratio were analyzed. Among 1,171 patients, 255 patients (21.8%) were diagnosed as PCA. Multivariate analyses showed that patient age, prostate volume, PSA and percent free PSA had statistically significant relationships with PCA (P < 0.05) and were used as nomogram predictor variables. The area under the (ROC) curve for all factors in a model predicting PCA was 0.759 (95% CI, 0.716-0.803).
AbstractList Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy is still necessary to confirm prostate cancer (PCA). However, it is reported that PSA is associated with a high false-positive rate and prostate biopsy also has various procedure-related complications. Therefore, the authors have devised a nomogram, which can be used to estimate the risk of PCA, using available clinical data for men with a serum PSA less than 10 ng/mL. Prostate biopsies were obtained from 2,139 patients from January 1998 to March 2011. Of them, 1,171 patients with a serum PSA less than 10 ng/mL were only included in this study. Patient age, PSA, free PSA, prostate volume, PSA density and percent free PSA ratio were analyzed. Among 1,171 patients, 255 patients (21.8%) were diagnosed as PCA. Multivariate analyses showed that patient age, prostate volume, PSA and percent free PSA had statistically significant relationships with PCA (P < 0.05) and were used as nomogram predictor variables. The area under the (ROC) curve for all factors in a model predicting PCA was 0.759 (95% CI, 0.716-0.803).
Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy is still necessary to confirm prostate cancer (PCA). However, it is reported that PSA is associated with a high false-positive rate and prostate biopsy also has various procedure-related complications. Therefore, the authors have devised a nomogram, which can be used to estimate the risk of PCA, using available clinical data for men with a serum PSA less than 10 ng/mL. Prostate biopsies were obtained from 2,139 patients from January 1998 to March 2011. Of them, 1,171 patients with a serum PSA less than 10 ng/mL were only included in this study. Patient age, PSA, free PSA, prostate volume, PSA density and percent free PSA ratio were analyzed. Among 1,171 patients, 255 patients (21.8%) were diagnosed as PCA. Multivariate analyses showed that patient age, prostate volume, PSA and percent free PSA had statistically significant relationships with PCA (P < 0.05) and were used as nomogram predictor variables. The area under the (ROC) curve for all factors in a model predicting PCA was 0.759 (95% CI, 0.716-0.803).Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy is still necessary to confirm prostate cancer (PCA). However, it is reported that PSA is associated with a high false-positive rate and prostate biopsy also has various procedure-related complications. Therefore, the authors have devised a nomogram, which can be used to estimate the risk of PCA, using available clinical data for men with a serum PSA less than 10 ng/mL. Prostate biopsies were obtained from 2,139 patients from January 1998 to March 2011. Of them, 1,171 patients with a serum PSA less than 10 ng/mL were only included in this study. Patient age, PSA, free PSA, prostate volume, PSA density and percent free PSA ratio were analyzed. Among 1,171 patients, 255 patients (21.8%) were diagnosed as PCA. Multivariate analyses showed that patient age, prostate volume, PSA and percent free PSA had statistically significant relationships with PCA (P < 0.05) and were used as nomogram predictor variables. The area under the (ROC) curve for all factors in a model predicting PCA was 0.759 (95% CI, 0.716-0.803).
Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy isstill necessary to confirm prostate cancer (PCA). However, it is reported that PSA isassociated with a high false-positive rate and prostate biopsy also has various procedurerelatedcomplications. Therefore, the authors have devised a nomogram, which can beused to estimate the risk of PCA, using available clinical data for men with a serum PSAless than 10 ng/mL. Prostate biopsies were obtained from 2,139 patients from January1998 to March 2011. Of them, 1,171 patients with a serum PSA less than 10 ng/mL wereonly included in this study. Patient age, PSA, free PSA, prostate volume, PSA density andpercent free PSA ratio were analyzed. Among 1,171 patients, 255 patients (21.8%) werediagnosed as PCA. Multivariate analyses showed that patient age, prostate volume, PSAand percent free PSA had statistically significant relationships with PCA (P < 0.05) andwere used as nomogram predictor variables. The area under the (ROC) curve for all factorsin a model predicting PCA was 0.759 (95% CI, 0.716-0.803). KCI Citation Count: 2
Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy is still necessary to confirm prostate cancer (PCA). However, it is reported that PSA is associated with a high false-positive rate and prostate biopsy also has various procedure-related complications. Therefore, the authors have devised a nomogram, which can be used to estimate the risk of PCA, using available clinical data for men with a serum PSA less than 10 ng/mL. Prostate biopsies were obtained from 2,139 patients from January 1998 to March 2011. Of them, 1,171 patients with a serum PSA less than 10 ng/mL were only included in this study. Patient age, PSA, free PSA, prostate volume, PSA density and percent free PSA ratio were analyzed. Among 1,171 patients, 255 patients (21.8%) were diagnosed as PCA. Multivariate analyses showed that patient age, prostate volume, PSA and percent free PSA had statistically significant relationships with PCA ( P < 0.05) and were used as nomogram predictor variables. The area under the (ROC) curve for all factors in a model predicting PCA was 0.759 (95% CI, 0.716-0.803).
Author Lee, Jeong Zoo
Ahn, Jae Hyun
Ha, Hong Koo
Chung, Moon Kee
AuthorAffiliation Department of Urology and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
AuthorAffiliation_xml – name: Department of Urology and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
Author_xml – sequence: 1
  givenname: Jae Hyun
  surname: Ahn
  fullname: Ahn, Jae Hyun
  organization: Department of Urology and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
– sequence: 2
  givenname: Jeong Zoo
  surname: Lee
  fullname: Lee, Jeong Zoo
  organization: Department of Urology and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
– sequence: 3
  givenname: Moon Kee
  surname: Chung
  fullname: Chung, Moon Kee
  organization: Department of Urology and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
– sequence: 4
  givenname: Hong Koo
  orcidid: 0000-0002-8240-7765
  surname: Ha
  fullname: Ha, Hong Koo
  organization: Department of Urology and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24616581$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001858339$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kU1vEzEQhi1URD_gD3BAPnLZ1B9rr31BiqIClSJAtJwtxztO3Ozawd6A-Pc4DbTAgdOMZ553ZuT3HJ3EFAGhl5TMOG_l5d12LDNGaDtjesZrTT1BZ1Ro1UguupOaE0obpXl7is5LuSOECcH4M3TKWkmlUPQMrT6kMa2zHbFPGX_K0Ac3hRRx8vWVymQnwAsbHWT8PUwbfAN5Pz62bnbggg8Oz-MU1hDxEkrB08ZGTAmO68tx-Rw99XYo8OJXvEBf3l7dLt43y4_vrhfzZeNaLqaGes-c7yVQkEJL5ywQDW0ra95pQon1qvO91h1fUQZW2lZKzS2o3llGPb9Ar49zY_Zm64JJNtzHdTLbbOafb6-N6DjpWEXfHNHdfjVC7yBO2Q5ml8No84974d-dGDZ1zDfDdSso6x537XL6uocymTEUB8NgI6R9MVQQ2SnNpKzoqz93PSz57UEF2BFw9VNLBv-AUGIORpuD0eZgtGHa8FpTVaT-EblQDanO1XvD8D_pT9Lgr5k
CitedBy_id crossref_primary_10_1007_s00432_017_2389_3
crossref_primary_10_1002_pros_24625
crossref_primary_10_1186_s12894_022_01116_2
crossref_primary_10_1371_journal_pone_0106933
crossref_primary_10_1097_MD_0000000000028196
crossref_primary_10_14366_usg_15065
crossref_primary_10_1016_j_ajur_2015_04_023
crossref_primary_10_1016_j_crad_2019_02_002
crossref_primary_10_3349_ymj_2016_57_3_565
crossref_primary_10_12688_f1000research_18892_1
crossref_primary_10_29220_CSAM_2021_28_4_339
crossref_primary_10_1186_s12889_021_10730_y
crossref_primary_10_1016_j_diabres_2018_05_036
crossref_primary_10_29220_CSAM_2018_25_3_297
crossref_primary_10_1016_j_afju_2017_09_004
Cites_doi 10.1111/j.1464-410X.1987.tb09137.x
10.1016/S0090-4295(02)02287-2
10.1056/NEJMoa031918
10.1111/j.1442-2042.2008.02058.x
10.1016/j.urology.2011.04.042
10.1016/j.eururo.2010.08.041
10.1016/S0090-4295(98)00205-2
10.1056/NEJM199104253241702
10.1016/j.juro.2009.11.043
10.1016/j.eururo.2012.06.003
10.1016/S0090-4295(97)00451-2
10.1097/01.ju.0000158039.94467.5d
10.1056/NEJMoa0810084
10.1016/S0090-4295(99)00213-7
10.1016/j.eururo.2011.12.058
10.1093/annonc/mdi098
10.1007/s10552-006-0087-6
10.1056/NEJMoa0810696
10.1016/j.juro.2011.06.057
ContentType Journal Article
Copyright 2014 The Korean Academy of Medical Sciences. 2014
Copyright_xml – notice: 2014 The Korean Academy of Medical Sciences. 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ACYCR
DOI 10.3346/jkms.2014.29.3.338
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1598-6357
EndPage 342
ExternalDocumentID oai_kci_go_kr_ARTI_573072
PMC3945127
24616581
10_3346_jkms_2014_29_3_338
Genre Journal Article
GroupedDBID ---
29K
2WC
3O-
5-W
53G
5GY
8JR
8XY
9ZL
AAYXX
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
CS3
D-I
DIK
DU5
E3Z
EBS
EF.
EJD
F5P
FRP
GROUPED_DOAJ
GX1
HYE
KQ8
M48
O5R
O5S
OK1
OVT
PGMZT
RNS
RPM
TR2
W2D
XSB
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
08R
ACYCR
M~E
ID FETCH-LOGICAL-c435t-1ff2cfd6e1e6596ccae09e44696c79010af87fd9973b12ea6a46693ae8dca21f3
IEDL.DBID M48
ISSN 1011-8934
1598-6357
IngestDate Tue Nov 21 21:35:27 EST 2023
Thu Aug 21 14:05:33 EDT 2025
Fri Jul 11 06:54:17 EDT 2025
Mon Jul 21 05:50:35 EDT 2025
Tue Jul 01 01:44:49 EDT 2025
Thu Apr 24 23:09:55 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Prostatic Neoplasms
Biopsy
Prostate
Nomograms
Language English
License http://creativecommons.org/licenses/by-nc/3.0
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c435t-1ff2cfd6e1e6596ccae09e44696c79010af87fd9973b12ea6a46693ae8dca21f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000345.2014.29.3.014
ORCID 0000-0002-8240-7765
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3346/jkms.2014.29.3.338
PMID 24616581
PQID 1506789266
PQPubID 23479
PageCount 5
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_573072
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3945127
proquest_miscellaneous_1506789266
pubmed_primary_24616581
crossref_primary_10_3346_jkms_2014_29_3_338
crossref_citationtrail_10_3346_jkms_2014_29_3_338
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-03-01
PublicationDateYYYYMMDD 2014-03-01
PublicationDate_xml – month: 03
  year: 2014
  text: 2014-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Journal of Korean medical science
PublicationTitleAlternate J Korean Med Sci
PublicationYear 2014
Publisher The Korean Academy of Medical Sciences
대한의학회
Publisher_xml – name: The Korean Academy of Medical Sciences
– name: 대한의학회
References 10.3346/jkms.2014.29.3.338_ref3
Nam (10.3346/jkms.2014.29.3.338_ref16) 2010; 183
Andriole (10.3346/jkms.2014.29.3.338_ref4) 2009; 360
Ilic (10.3346/jkms.2014.29.3.338_ref11) 2007; 18
Carlson (10.3346/jkms.2014.29.3.338_ref18) 1998; 52
10.3346/jkms.2014.29.3.338_ref1
Boyle (10.3346/jkms.2014.29.3.338_ref2) 2005; 16
Ferro (10.3346/jkms.2014.29.3.338_ref13) 1987; 60
Catalona (10.3346/jkms.2014.29.3.338_ref5) 1991; 324
Schröder (10.3346/jkms.2014.29.3.338_ref6) 2009; 360
Gancarczyk (10.3346/jkms.2014.29.3.338_ref10) 2003; 61
Chun (10.3346/jkms.2014.29.3.338_ref8) 2010; 58
Loeb (10.3346/jkms.2014.29.3.338_ref14) 2011; 186
Kawamura (10.3346/jkms.2014.29.3.338_ref17) 2008; 15
Zaytoun (10.3346/jkms.2014.29.3.338_ref22) 2011; 78
Wang (10.3346/jkms.2014.29.3.338_ref12) 1979; 17
Wagenlehner (10.3346/jkms.2014.29.3.338_ref9) 2013; 63
Eastham (10.3346/jkms.2014.29.3.338_ref19) 1999; 54
Loeb (10.3346/jkms.2014.29.3.338_ref15) 2012; 61
Karakiewicz (10.3346/jkms.2014.29.3.338_ref20) 2005; 173
Optenberg (10.3346/jkms.2014.29.3.338_ref21) 1997; 50
Thompson (10.3346/jkms.2014.29.3.338_ref7) 2004; 350
15163773 - N Engl J Med. 2004 May 27;350(22):2239-46
89106 - Invest Urol. 1979 Sep;17(2):159-63
1707140 - N Engl J Med. 1991 Apr 25;324(17):1156-61
10510933 - Urology. 1999 Oct;54(4):709-13
9372872 - Urology. 1997 Nov;50(5):665-72
19297565 - N Engl J Med. 2009 Mar 26;360(13):1310-9
9730460 - Urology. 1998 Sep;52(3):455-61
22244150 - Eur Urol. 2012 Jun;61(6):1110-4
12639653 - Urology. 2003 Mar;61(3):589-95
22704727 - Eur Urol. 2013 Mar;63(3):521-7
18462353 - Int J Urol. 2008 Jul;15(7):598-603
20089283 - J Urol. 2010 Mar;183(3):963-8
2441790 - Br J Urol. 1987 Jul;60(1):69-73
20884114 - Eur Urol. 2010 Dec;58(6):851-64
21705045 - Urology. 2011 Aug;78(2):392-8
15879784 - J Urol. 2005 Jun;173(6):1930-4
21944136 - J Urol. 2011 Nov;186(5):1830-4
15718248 - Ann Oncol. 2005 Mar;16(3):481-8
17206534 - Cancer Causes Control. 2007 Apr;18(3):279-85
19297566 - N Engl J Med. 2009 Mar 26;360(13):1320-8
References_xml – ident: 10.3346/jkms.2014.29.3.338_ref1
– volume: 60
  start-page: 69
  year: 1987
  ident: 10.3346/jkms.2014.29.3.338_ref13
  publication-title: Br J Urol
  doi: 10.1111/j.1464-410X.1987.tb09137.x
– ident: 10.3346/jkms.2014.29.3.338_ref3
– volume: 61
  start-page: 589
  year: 2003
  ident: 10.3346/jkms.2014.29.3.338_ref10
  publication-title: Urology
  doi: 10.1016/S0090-4295(02)02287-2
– volume: 350
  start-page: 2239
  year: 2004
  ident: 10.3346/jkms.2014.29.3.338_ref7
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa031918
– volume: 15
  start-page: 598
  year: 2008
  ident: 10.3346/jkms.2014.29.3.338_ref17
  publication-title: Int J Urol
  doi: 10.1111/j.1442-2042.2008.02058.x
– volume: 78
  start-page: 392
  year: 2011
  ident: 10.3346/jkms.2014.29.3.338_ref22
  publication-title: Urology
  doi: 10.1016/j.urology.2011.04.042
– volume: 58
  start-page: 851
  year: 2010
  ident: 10.3346/jkms.2014.29.3.338_ref8
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2010.08.041
– volume: 52
  start-page: 455
  year: 1998
  ident: 10.3346/jkms.2014.29.3.338_ref18
  publication-title: Urology
  doi: 10.1016/S0090-4295(98)00205-2
– volume: 324
  start-page: 1156
  year: 1991
  ident: 10.3346/jkms.2014.29.3.338_ref5
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199104253241702
– volume: 183
  start-page: 963
  year: 2010
  ident: 10.3346/jkms.2014.29.3.338_ref16
  publication-title: J Urol
  doi: 10.1016/j.juro.2009.11.043
– volume: 63
  start-page: 521
  year: 2013
  ident: 10.3346/jkms.2014.29.3.338_ref9
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2012.06.003
– volume: 50
  start-page: 665
  year: 1997
  ident: 10.3346/jkms.2014.29.3.338_ref21
  publication-title: Urology
  doi: 10.1016/S0090-4295(97)00451-2
– volume: 173
  start-page: 1930
  year: 2005
  ident: 10.3346/jkms.2014.29.3.338_ref20
  publication-title: J Urol
  doi: 10.1097/01.ju.0000158039.94467.5d
– volume: 360
  start-page: 1320
  year: 2009
  ident: 10.3346/jkms.2014.29.3.338_ref6
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0810084
– volume: 17
  start-page: 159
  year: 1979
  ident: 10.3346/jkms.2014.29.3.338_ref12
  publication-title: Invest Urol
– volume: 54
  start-page: 709
  year: 1999
  ident: 10.3346/jkms.2014.29.3.338_ref19
  publication-title: Urology
  doi: 10.1016/S0090-4295(99)00213-7
– volume: 61
  start-page: 1110
  year: 2012
  ident: 10.3346/jkms.2014.29.3.338_ref15
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2011.12.058
– volume: 16
  start-page: 481
  year: 2005
  ident: 10.3346/jkms.2014.29.3.338_ref2
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdi098
– volume: 18
  start-page: 279
  year: 2007
  ident: 10.3346/jkms.2014.29.3.338_ref11
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-006-0087-6
– volume: 360
  start-page: 1310
  year: 2009
  ident: 10.3346/jkms.2014.29.3.338_ref4
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0810696
– volume: 186
  start-page: 1830
  year: 2011
  ident: 10.3346/jkms.2014.29.3.338_ref14
  publication-title: J Urol
  doi: 10.1016/j.juro.2011.06.057
– reference: 17206534 - Cancer Causes Control. 2007 Apr;18(3):279-85
– reference: 18462353 - Int J Urol. 2008 Jul;15(7):598-603
– reference: 10510933 - Urology. 1999 Oct;54(4):709-13
– reference: 15718248 - Ann Oncol. 2005 Mar;16(3):481-8
– reference: 21944136 - J Urol. 2011 Nov;186(5):1830-4
– reference: 22704727 - Eur Urol. 2013 Mar;63(3):521-7
– reference: 89106 - Invest Urol. 1979 Sep;17(2):159-63
– reference: 22244150 - Eur Urol. 2012 Jun;61(6):1110-4
– reference: 19297565 - N Engl J Med. 2009 Mar 26;360(13):1310-9
– reference: 21705045 - Urology. 2011 Aug;78(2):392-8
– reference: 15879784 - J Urol. 2005 Jun;173(6):1930-4
– reference: 9372872 - Urology. 1997 Nov;50(5):665-72
– reference: 9730460 - Urology. 1998 Sep;52(3):455-61
– reference: 12639653 - Urology. 2003 Mar;61(3):589-95
– reference: 20884114 - Eur Urol. 2010 Dec;58(6):851-64
– reference: 1707140 - N Engl J Med. 1991 Apr 25;324(17):1156-61
– reference: 19297566 - N Engl J Med. 2009 Mar 26;360(13):1320-8
– reference: 2441790 - Br J Urol. 1987 Jul;60(1):69-73
– reference: 20089283 - J Urol. 2010 Mar;183(3):963-8
– reference: 15163773 - N Engl J Med. 2004 May 27;350(22):2239-46
SSID ssj0025523
Score 2.069654
Snippet Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy is still necessary to confirm prostate cancer (PCA). However, it is...
Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy isstill necessary to confirm prostate cancer (PCA). However, it is...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 338
SubjectTerms Adult
Age Factors
Aged
Aged, 80 and over
Area Under Curve
Humans
Male
Middle Aged
Multivariate Analysis
Nomograms
Original
Predictive Value of Tests
Prostate - physiology
Prostate-Specific Antigen - blood
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - pathology
Risk Factors
ROC Curve
의학일반
Title Nomogram for Prediction of Prostate Cancer with Serum Prostate Specific Antigen Less than 10 ng/mL
URI https://www.ncbi.nlm.nih.gov/pubmed/24616581
https://www.proquest.com/docview/1506789266
https://pubmed.ncbi.nlm.nih.gov/PMC3945127
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001858339
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Korean Medical Science, 2014, 29(3), 186, pp.338-342
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1598-6357
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025523
  issn: 1011-8934
  databaseCode: KQ8
  dateStart: 19860101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1598-6357
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025523
  issn: 1011-8934
  databaseCode: DOA
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1598-6357
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025523
  issn: 1011-8934
  databaseCode: DIK
  dateStart: 19860101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1598-6357
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025523
  issn: 1011-8934
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 1598-6357
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025523
  issn: 1011-8934
  databaseCode: 5-W
  dateStart: 19860101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1598-6357
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025523
  issn: 1011-8934
  databaseCode: RPM
  dateStart: 19860101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1598-6357
  dateEnd: 20250831
  omitProxy: true
  ssIdentifier: ssj0025523
  issn: 1011-8934
  databaseCode: M48
  dateStart: 19860901
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwED9tQ0K8IL4pH5WREC8opc6X4weEEGLagO2JSnuzXMceU9uky1oJ_nvul6SFooF4aho7tXp3jn_nO_-O6KUDLVEpQ-Qw3XiFUJH2PouyqVI4sTJOQ8v2eZofTdJPZ9nZHm3SbXsBXl3r2qGe1KSZj75f_njHE_4tPM4EEcrZAsTbMh3FepTwveLV8jJCYSkEYPsqG_t0gxerGIZ_km4DDQyo2wpwvKgXEajZunM1f_nZnbVrv2rCdbD0z-zK35arwzt0u8eZ4n1nGHdpz1f36OZJH0m_T9PTetFmZglGrWLZoAE6EnXgb3V7zkg4mEQjsFcr2FTXi19NOKGJLCPBmgGhp5jzK1NgH17IsajO3yy-PKDJ4cevH46ivt5C5Bg0rSIZQuxCmXvp80znrFs_1p79Rb5WSOOwoVCh1FolUxl7m9s0z3VifVE6G8uQPKSDqq78YxIg6UlLaRkvWRDW2CQNTjEalTHP-lwPSG4kaVxPRo6aGHPDTgmkbyB9A-mbWJuE7xUDer19ZtlRcfyz9wtWkJm5CwMGbXye12bWGPYTjk3GLzYVc5-N-gzPKoRKbOXr9ZUB76IqNKOXAT3q1LkdEwx8jNvkgNSOorcdMN5uS3XxrWXuTnTKAEs9-Y9xn9It_J8u3e0ZHayatX_O-Gc1HTLyP_48bHcPhq01_wSEDAUo
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nomogram+for+prediction+of+prostate+cancer+with+serum+prostate+specific+antigen+less+than+10+ng%2FmL&rft.jtitle=Journal+of+Korean+medical+science&rft.au=Ahn%2C+Jae+Hyun&rft.au=Lee%2C+Jeong+Zoo&rft.au=Chung%2C+Moon+Kee&rft.au=Ha%2C+Hong+Koo&rft.date=2014-03-01&rft.issn=1598-6357&rft.eissn=1598-6357&rft.volume=29&rft.issue=3&rft.spage=338&rft_id=info:doi/10.3346%2Fjkms.2014.29.3.338&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-8934&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-8934&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-8934&client=summon